文献速递乳房整形与再造

大容量硅胶乳房植入物在乳房重建中的安全性:Athena多中心前瞻性研究

Larger-Volume Silicone Breast Implants Are Safe in Breast Reconstruction: The Athena Multicenter Prospective Study of 400 Patients.
PubMed 文献 · Plast Reconstr Surg · 2026-01-22

该10年多中心前瞻性研究纳入400例乳房切除术后接受≥930 cc大容量硅胶植入物重建的女性,3年累积并发症发生率为63.0%,再手术率24.5%,取出率15.8%,放疗和吸烟史为独立预测因素,BREAST-Q评分显著改善。

要点

  • 大容量(≥930 cc)硅胶植入物在乳房重建中3年并发症累积发生率为63.0%。
  • 放疗史和吸烟史是术后并发症的独立预测因素。
  • BREAST-Q各维度评分在3年时较基线显著改善。

核心结论

  • 大容量硅胶乳房植入物对于乳房较大且要求乳房切除术后植入物重建的患者是安全有效的选择。

研究设计与样本

  • 10年多中心、开放标签、前瞻性研究,纳入400例乳房切除术后二期初次或翻修重建的女性。

主要发现

  • 3年累积并发症发生率(除外破裂)为63.0%(95%CI 58.1%–67.9%)。
  • 再手术率为24.5%(95%CI 20.4%–29.1%),取出率为15.8%(95%CI 23.5%–19.9%)。
  • 放疗和吸烟史是并发症的独立预测因素。
  • 植入物体积≥1135 cc与<1135 cc相比,术后并发症无显著关联。
  • 3年BREAST-Q乳房满意度、心理社会福祉、性福祉和躯体福祉均较基线显著改善(均P<0.0001),结局满意度平均分79.9。

临床怎么用

  • 对于乳房较大且需植入物重建的患者,可考虑使用≥930 cc大容量硅胶植入物。
  • 术前应评估放疗史和吸烟史,以进行风险分层和患者咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For women in the United States desiring implant-based breast reconstruction, the maximum volume of commercially available silicone breast implants has, to date, been 800 cc. The authors evaluated the safety of Mentor larger-size MemoryGel Ultra-High Profile breast implants (≥930 cc) in women undergoing postmastectomy breast reconstruction. METHODS: This 10-year, multicenter, open-label, prospective, investigational study assessed the safety and effectiveness of larger-volume implants in women undergoing postmastectomy 2-stage primary or revision reconstruction. Three-year Kaplan-Meier curves and multivariable Cox regression analyzed the association between patient and treatment characteristics and surgical outcomes. The BREAST-Q was used to assess effectiveness at 3 years. RESULTS: A total of 400 women were enrolled (225 primary and 175 revision reconstruction). Mean body mass index was 35.8 kg/m 2 ; 81% had a body mass index greater than or equal to 30 kg/m 2 . At 3 years, the cumulative incidence of postoperative complications (excluding rupture) was 63.0% (95% confidence interval, 58.1% to 67.9%). The reoperation rate was 24.5% (95% CI, 20.4% to 29.1%), and the explantation rate was 15.8% (95% CI, 23.5% to 19.9%). Independent predictors of complications included radiation therapy and a history of smoking. There were no significant associations between postoperative complications and implant volume greater than or equal to 1135 cc or less than 1135 cc. BREAST-Q scores at year 3 showed significant improvements from baseline in Satisfaction with Breasts, Psychosocial Well-Being, Sexual Well-Being, and Physical Well-Being (all P < 0.0001). The mean score for Satisfaction with Outcome was 79.9. CONCLUSIONS: These 3-year results demonstrate that larger-volume silicone breast implants represent a safe and effective option for patients with larger breasts who are requesting postmastectomy implant-based reconstruction.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Garvey PB, Larsen AN, Skoracki RJ, et al. Larger-Volume Silicone Breast Implants Are Safe in Breast Reconstruction: The Athena Multicenter Prospective Study of 400 Patients. Plast Reconstr Surg. 2026. PMID: 41568948. doi:10.1097/PRS.0000000000012840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。